BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5346627)

  • 1. Sympathomimetic drugs in acute viral bronchiolitis. Their effect on pulmonary resistance.
    Phelan PD; Williams HE
    Pediatrics; 1969 Oct; 44(4):493-7. PubMed ID: 5346627
    [No Abstract]   [Full Text] [Related]  

  • 2. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
    Muittari A; Mattila MJ; Tiitinen H
    Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181
    [No Abstract]   [Full Text] [Related]  

  • 3. Exercise-induced bronchospasm: evaluation of metaproterenol.
    Sly RM; Heimlich EM; Ginsburg J; Busser RJ; Strick L
    Ann Allergy; 1968 May; 26(5):253-8. PubMed ID: 5654963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the bronchospasmolytic effect of alupent and aleudrine by spirometric examination of pulmonary ventilation].
    Juricić V
    Lijec Vjesn; 1970; 92(2):217-22. PubMed ID: 5202453
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance.
    Bäcklund L; Fagerberg E
    Scand J Respir Dis; 1968; 49(4):284-90. PubMed ID: 5194717
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
    Cardaci G; Vittore F; Bussa B
    Clin Ter; 1968 Jun; 44(6):533-41. PubMed ID: 5736873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ventilatory changes induced by bronchodilator aerosols in mitral stenosis. II. Patients with congestive cardiocirculatory insufficiency].
    Sarno A
    Boll Soc Ital Cardiol; 1966; 11(4):964-70. PubMed ID: 5992087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the use of a sympathomimetic aerosol for diagnostic and therapeutic use].
    Gaffuri E; Reggiani A
    Clin Ter; 1967 Dec; 43(6):559-65. PubMed ID: 5617981
    [No Abstract]   [Full Text] [Related]  

  • 9. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P; Falholt W
    Ugeskr Laeger; 1971 Apr; 133(15):685-8. PubMed ID: 4396922
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of orciprenaline on circulation in the lung].
    Daum S; Stiksa J; Nikodýmová L; Petrle A; Svorcik C
    Arzneimittelforschung; 1967 May; 17(5):565-8. PubMed ID: 5631585
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine.
    Muittari A; Mattila MJ; Patiala J
    Ann Allergy; 1969 Jun; 27(6):274-9. PubMed ID: 4891707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S; Tanaka Y; Wagatsuma Y; Miura R; Umezu A
    Arerugi; 1971 Aug; 20(8):599-609. PubMed ID: 4398383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the action of beta-sympathomimetic bronchodilator agents in chronic obstructive pneumopathy].
    Racoveanu C; Manicatide M
    Stud Cercet Med Interna; 1971; 12(2):151-60. PubMed ID: 5565346
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).
    Mattila MJ; Muittari A
    Ann Med Exp Biol Fenn; 1969; 47(4):298-302. PubMed ID: 4911261
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the treatment of bronchial asthma].
    Scherrer M; Wyss F
    Ther Umsch; 1967 Nov; 24(11):498-504. PubMed ID: 5600421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of labor pain inhibition by pharmacological agents].
    Mosler KH
    Med Klin; 1969 Jan; 64(4):133-9. PubMed ID: 5783923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of 1-(3,5-dihydroxyphenyl)-2-isopropylamino-ethanol sulfate on respiratory function and heart minute volume].
    Demiroglu C; Göksel F; Oztürk M; Obek A
    Arzneimittelforschung; 1968 Jun; 18(6):682-5. PubMed ID: 5756045
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the pulmonary physiological effect of sympathomimetic amines in bronchial asthma.
    Crosbie WA; Kidner PH; Miller JN; Pride NB
    J Asthma Res; 1971 Mar; 8(3):99-110. PubMed ID: 4932130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathological anatomy in heart insufficiency].
    Meessen H
    Arztl Forsch; 1967 Feb; 21(2):41-50. PubMed ID: 4873357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.